Evidence map›Paper›PMID 41300900›Full record

ReviewDiagnostics (Basel, Switzerland)2025

The Role of Nuclear Medicine in Prostate Cancer.

Isidora Grozdic Milojevic, Bogomir Milojevic, Daniel Skrijelj, Uros Bumbasirevic, Aleksandar Janicic, Boris Kajmakovic, Dragana Sobic-Saranovic, Vera Artiko, Slobodanka Beatovic

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isidora Grozdic MilojevicCenter of Nuclear Medicine and PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-3301-9456
Bogomir MilojevicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-6784-8389
Daniel SkrijeljClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-5835-4819
Uros BumbasirevicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0367-2745
Aleksandar JanicicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Boris KajmakovicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-5335-1830
Dragana Sobic-SaranovicCenter of Nuclear Medicine and PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Vera ArtikoCenter of Nuclear Medicine and PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Slobodanka BeatovicCenter of Nuclear Medicine and PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

evaluationhybrid imagingPET/CTprostatic cancerPSMAtargeted radioligand therapy

Identifiers

PMID41300900
PMCPMC12651400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.